The global molecular diagnostics market is projected to grow from $23 billion in 2025 to $42.6 billion by 2030, driven by factors like the increasing prevalence of infectious diseases and the need for early detection of chronic conditions like cancer. Technologies like PCR and NGS are key in this market, with applications expanding to include transplantation and non-invasive cancer testing.

The report provides a detailed analysis of the market, covering segments such as technology, product and service type, application, and region. Key trends driving market growth include point-of-care testing and companion diagnostics for targeted therapies. North America currently leads the market, with PCR technology dominating and companies like Abbott and Roche being market leaders.

Emerging startups in the molecular diagnostics field include Sherlock Biosciences, Tempus AI, and Guardant Health, showcasing the innovation and competition in this rapidly growing market. The report also addresses challenges such as stringent regulations and high costs, while highlighting opportunities in developing point-of-care tests and companion diagnostics.

For further insights into the market dynamics and key players, related reports on oncology diagnostics and colorectal cancer screening are available. BCC Research’s market research reports aim to provide objective and unbiased assessments to help businesses make informed decisions in the ever-evolving field of molecular diagnostics.

To learn more or purchase a copy of the report, contact BCC Research at [email protected]. Stay informed with their media page for access to a library of market research reports, ensuring accurate and reliable information for media use. Remember to credit BCC Research LLC as the original source for any data or analysis extracted from this press release.

Read more at GlobeNewswire: Molecular Diagnostics Market to Grow at 13.1% CAGR Through